Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2025 15:59 ET | Source: Abvance Therapeutics

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions

Abvance closes seed round led by Zubi Capital to advance glucagon-based therapies aimed at preventing hypoglycemia in people with diabetes.